Related Experiment Videos
Acute lymphocytic leukemia in adults: an update
1Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston.
Texas Medicine
|January 1, 1994
Summary
Prognosis for adults with acute lymphocytic leukemia has improved. Modern chemotherapy yields high complete response rates and better long-term survival for this leukemia.
Area of Science:
- Hematology
- Oncology
- Internal Medicine
Background:
- Adult acute lymphocytic leukemia (ALL) historically has a poorer prognosis than pediatric ALL.
- Significant advancements in treatment strategies have been observed over the past 20 years.
Purpose of the Study:
- To review the clinical, laboratory, and prognostic features of adult ALL.
- To discuss the outcomes of contemporary therapeutic approaches for adult ALL.
Main Methods:
- Review of existing literature on adult acute lymphocytic leukemia.
- Analysis of clinical data, laboratory findings, and prognostic indicators.
- Evaluation of treatment response and survival rates.
Main Results:
- Complete response rates for adult ALL range from 75% to 85% with intensive chemotherapy.
- Long-term, disease-free survival rates have improved, now between 20% and 35%.
Conclusions:
- Modern chemotherapy regimens have significantly improved the prognosis for adults with acute lymphocytic leukemia.
- Further research into prognostic factors and novel therapies is warranted to enhance survival outcomes.